The UCSF Fetal Treatment Center has been on the forefront of fetal treatment research since it's inception. The first open fetal surgery in the world was performed at UCSF over 2 decades ago and we continue to dedicate ourselves to research and innovation.
The aim of IFCIR is to improve the care and outcome for mothers and babies when the pregnancy is complicated by congenital heart disease in the fetus. Specifically, through this website we share our experiences, protocols, technical aspects and outcome data for fetal patients with congenital heart disease potentially amenable to intervention before birth.
IFCIR represents an independent group of medical centers and healthcare professionals, endorsed by the leading scientific organizations of physicians working in this field,
For more information visit the IFCIR website.
Study analyzing fetal surgery and preterm labor.
Study analyzing the maternal risks of fetal surgical interventions.
Golombeck K, Ball RH, Lee H, Farrell JA, Farmer DL, Jacobs VR, Rosen MA, Filly RA, Harrison MR. Maternal morbidity after maternal-fetal surgery. Am J Obstet Gynecol. 2006 Mar;194(3):834-9.
Examination of a novel preventive “presealant” to protect amniotic membranes during fetal surgery.
Cortes RA, Wagner AJ, Lee H, Clifton MS, Grethel E, Yang SH, Ball R, Harrison MR. Pre-emptive placement of a presealant for amniotic access. Am J Obstet Gynecol. 2005 Sep;193(3 Pt 2):1197-203
Study evaluting recent advances in fetal treatment.
The innovative procedures at FTC saved the lives of both Angela and Guy, whom were both diagnosed with severe CCAMs.